HealthDay News — Combining human papillomavirus (HPV) DNA testing with cytology testing at first screening resulted in fewer cases of high-grade cervical intraepithelial neoplasia (CIN) lesions and ...

Illustrative picture of human papillomavirus (HPV) vaccine. Credit: Getty Images. Primary care providers have a critical role in human papillomavirus (HPV) screening and prevention. Human ...

Testing for low-risk human papillomavirus (HPV) types should be excluded from cervical cancer screening because such tests fail to predict risk of developing cervical intraepithelial neoplasia (CIN) ...

(NEW YORK) — Although most women are accustomed to having Pap smears to test for cervical cancer — a disease that strikes 12,000 American women each year, according to the U.S. Centers for Disease ...

This prospective, multicenter validation study accrued patients with stage IB-IVA cervical cancer treated with CRT between 2017 and 2022. Participants underwent phlebotomy at baseline, end of CRT, 4-6 ...

Final results of a phase 2 study of tucatinib and trastuzumab for HER2-positive mCRC (MOUNTAINEER). Phase I trial of hypoxia-responsive CEA CAR-T cell therapy in patients with heavily pretreated solid ...

HPV-positive circulating tumor (ct)DNA after chemoradiation (CRT) for cervical cancer had an independent association with worse outcomes, suggesting potential as a biomarker to guide decision-making, ...

Harvard Medical School-affiliated researchers recently revealed a new technique to help doctors detect head and neck cancers caused by strains of human papillomavirus up to 10 years prior to diagnosis ...

Human papilloma virus (HPV) causes around 70% of head and neck cancers in the United States, making it the most common cancer caused by the virus, with rates increasing each year. Unlike cervical ...

Subscribe to our newsletter and stay updated on the latest developments and special offers!